CureVac N.V. — Investor Relations & Filings
Filings indexed
250
across all filing types
Latest filing
2026-01-16
Regulatory Filings
Country
US
United States of America
Listing
US
CVAC
CureVac N.V. is a global biopharmaceutical company that develops transformative medicines based on messenger ribonucleic acid (mRNA). With over two decades of experience, the company leverages its proprietary mRNA technology platform to enable the human body to produce its own therapeutic proteins to fight a wide range of diseases. CureVac's clinical development pipeline is focused on creating prophylactic vaccines for infectious diseases, as well as therapies in oncology and for rare diseases. The company collaborates with partners to advance its portfolio of mRNA-based candidates.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 15-12G | 2026-01-16 | English | |
| S-8 POS | 2026-01-07 | English | |
| Delisting Announcement 2026 | 2026-01-06 | English | |
| 6-K | 2026-01-06 | English | |
| SC 14D9/A | 2025-12-18 | English | |
| Major Shareholding Notification 2025 | 2025-12-12 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 13250193 | 15-12G | 2026-01-16 | English | ||
| 13250194 | S-8 POS | 2026-01-07 | English | ||
| 13250195 | Delisting Announcement 2026 | 2026-01-06 | English | ||
| 13250196 | 6-K | 2026-01-06 | English | ||
|
2025
11 filings
| |||||
| 13250197 | SC 14D9/A | 2025-12-18 | English | ||
| 13250198 | Major Shareholding Notification 2025 | 2025-12-12 | English | ||
| 13250199 | Major Shareholding Notification 2025 | 2025-12-12 | English | ||
| 13250200 | Major Shareholding Notification 2025 | 2025-12-12 | English | ||
| 13250201 | SC 14D9/A | 2025-12-05 | English | ||
| 13250202 | SC 14D9/A | 2025-11-26 | English | ||
| 13250203 | FORM 6-K | 2025-11-26 | English | ||
| 13250204 | SC 14D9/A | 2025-11-25 | English | ||
| 13250205 | SC 14D9/A | 2025-11-24 | English | ||
| 13250206 | FORM 6-K | 2025-11-24 | English | ||
| 13250207 | FORM 6-K | 2025-10-27 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Caplin Point Laboratories Ltd.
Develops and manufactures finished dosage forms for Latin A…
|
CAPLIPOINT | IN | Manufacturing |
|
CAPRICOR THERAPEUTICS, INC.
A clinical-stage biotech developing cell and exosome-based …
|
CAPR | US | Manufacturing |
|
Cardiogeni Plc
A clinical-stage biotech developing regenerative medicines …
|
— | GB | Manufacturing |
|
Cardiol Therapeutics Inc.
Clinical-stage company developing anti-inflammatory and ant…
|
CRDL | CA | Manufacturing |
|
CAREGEN CO.,LTD.
Develops biomimetic peptides and growth factors for aesthet…
|
214370 | KR | Manufacturing |
|
Caribou Biosciences, Inc.
Clinical-stage biopharma developing genome-edited allogenei…
|
CRBU | US | Manufacturing |
|
Carisma Therapeutics Inc.
A clinical-stage biotech developing engineered macrophage-b…
|
CARM | US | Manufacturing |
|
Carna Biosciences, Inc.
Clinical-stage biopharma developing small molecule kinase i…
|
4572 | JP | Manufacturing |
|
CARsgen Therapeutics Holdings Limited
Clinical-stage biopharma focused on developing innovative C…
|
2171 | HK | Manufacturing |
|
Cartesian Therapeutics, Inc.
A clinical-stage company developing mRNA-engineered cell th…
|
RNAC | US | Manufacturing |
CureVac N.V. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32086/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32086 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32086 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32086 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32086}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CureVac N.V. (id: 32086)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.